サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427895

先天性代謝異常症向け医療用食品の世界市場レポート 2024

Medical Foods For Inborn Errors Of Metabolism Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
先天性代謝異常症向け医療用食品の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

先天性代謝異常症向け医療用食品の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.9%の年間複合成長率（CAGR）で48億3,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、遠隔医療の統合、クリーンラベル製品への需要の増加、新生児スクリーニングプログラムの延長、患者中心のケアモデルの採用、プラント開発など、さまざまな要因に関連している可能性があります。に基づいた持続可能な配合。予測期間中に予想される主な動向には、遺伝子検査の技術進歩、食品加工技術の進歩、成分技術の革新、食品配合技術の継続的な進化が含まれます。

遺伝性（先天性）疾患の予測増加は、将来の先天性代謝異常症向け医療用食品市場の成長の主要な原動力になると予想されます。典型的なDNA配列の逸脱に起因する遺伝的疾患は、医療用食品によって提供される特殊な栄養に対する需要に寄与すると予想されます。これらの製品は、代謝異常のある個人の特有の代謝ニーズに対処し、栄養不足を防ぎ、全体的な成長と幸福を促進する上で重要な役割を果たします。たとえば、2021年5月のデータによると、米国だけでも毎年20万人に1人が遺伝子変異により症候群Aと診断されている一方、全世界で1万5000人の症候群B患者が特定されています。この遺伝性疾患の急増は、先天性代謝異常症向け医療用食品市場の成長を推進する重要な要因です。

高齢化人口の増加により、今後数年間で先天性代謝異常症向け医療用食品市場の拡大が促進される見通しです。人口の高齢化傾向は、世界的に高齢者の割合が増加していることを特徴としており、高齢者の特定の疾患に特有の栄養要件と代謝の問題に関連した課題を提示しています。特に、世界保健機関が2022年 10月に発表した予測では、2030年までに世界中の6人に1人が60歳以上になると推定されています。この期間中に、60歳以上の人口は2020年の10億人から14億人に増加すると予想されています。今後、世界の60歳以上の人口は倍増し、2050年までに21億人に達すると予想されています。その結果、高齢化人口の増加が、先天性代謝異常症向け医療用食品市場の成長を促進する重要な要因として浮上しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の先天性代謝異常症向け医療用食品市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • アミノ酸
  • GMP含有グリタクチン、鉄含有アミノ酸改変乳児用調製乳
  • 低カルシウム/ビタミンDフリーの鉄分配合乳児用調製乳
  • 低タンパク質食品
  • その他の製品
  • 世界の先天性代謝異常症向け医療用食品市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • フェニルケトン尿症（PKU）
  • メープルシロップ尿症（MSUD）
  • ホモシスチン尿症
  • メチルマロン酸血症
  • 有機酸類
  • プロピオン酸血症
  • イソ吉草酸血症
  • ロイシン代謝障害
  • グルタル酸血症I型腎疾患
  • その他の病気
  • 世界の先天性代謝異常症向け医療用食品市場、年齢層別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 幼児
  • 離乳
  • 思春期
  • 大人
  • 世界の先天性代謝異常症向け医療用食品市場、形態別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 粉末
  • 液体
  • ジェル
  • その他の形式
  • 世界の先天性代謝異常症向け医療用食品市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 小売薬局
  • 病院薬局
  • ドラッグストア
  • オンライン薬局
  • その他の流通チャネル

第7章 地域および国の分析

  • 世界の先天性代謝異常症向け医療用食品市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の先天性代謝異常症向け医療用食品市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 先天性代謝異常症向け医療用食品市場の競合情勢
  • 先天性代謝異常症向け医療用食品市場の企業プロファイル
    • BASF SE
    • Abbott Laboratories Inc
    • Danone SA
    • Bristol-Myers Squibb Co
    • Meiji Holdings Co Ltd.

第31章 その他の大手および革新的な企業

  • Nestle Health Science SA
  • Ajinomoto Corporation
  • Mount Sinai Health System
  • BioMarin Pharmaceutical Inc
  • Gerber Products Company
  • Metagenics Inc.
  • Vitaflo International
  • SHS International Limited
  • Merck$Co Inc.
  • Galen Medical Group
  • Applied Nutrition Corp.
  • Primus Pharmaceuticals Inc.
  • Reckitt Benckiser Group Plc
  • Ener-G Foods Inc
  • Pristine Organics Pvt. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13739

Medical foods for inborn errors of metabolism encompass dietary supplements tailored for individuals with genetic conditions impacting metabolic functions. These products address specific nutritional needs in the management of these conditions. Key categories include amino acid formulations, glytactin with GMP amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron, low protein foods, and more. Amino acids, essential components found in living cells, are employed in medical foods for inborn errors of metabolism to offer alternative sources of crucial amino acids, bypassing those the individual's body struggles to metabolize effectively.

These medical foods cater to a range of disorders, including phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystinuria, methylmalonic acidemia, organic acidurias, propionic acidemia, isovaleric acidemia, disorders of leucine metabolism, glutaric acidemia type I, renal disease, and others. Tailored for various age groups such as infants, weaning, adolescents, and adults, these products are available in diverse forms such as powders, liquids, gels, and more. Distribution channels include retail pharmacies, hospital pharmacies, drug stores, online pharmacies, and other relevant outlets.

The medical foods for inborn errors of metabolism market research report is one of a series of new reports from The Business Research Company that provides medical foods for inborn errors of metabolism market statistics, including medical foods for inborn errors of metabolism industry global market size, regional shares, competitors with a medical foods for inborn errors of metabolism market share, detailed medical foods for inborn errors of metabolism market segments, medical foods for inborn errors of metabolism market trends and opportunities, and any further data you may need to thrive in the medical foods for inborn errors of metabolism industry. This medical foods for inborn errors of metabolism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical foods for inborn errors of metabolism market size has grown rapidly in recent years. It will grow from $2.72 billion in 2023 to $3.08 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The expansion observed during the historical period can be ascribed to several factors, including global health initiatives, heightened acknowledgment of nutritional therapies, the adoption of precision medicine approaches, a rising incidence of metabolic disorders, and the emergence of personalized digital nutrition platforms.

The medical foods for inborn errors of metabolism market size is expected to see rapid growth in the next few years. It will grow to $4.83 billion in 2028 at a compound annual growth rate (CAGR) of 11.9%. The anticipated growth in the forecast period can be linked to various factors, including the integration of telehealth, an increasing demand for clean label products, the extension of newborn screening programs, the adoption of patient-centric care models, and the development of plant-based and sustainable formulations. Key trends expected in the forecast period encompass technological advancements in genetic testing, progress in food processing technologies, innovations in ingredient technology, and the continuous evolution of food formulation technologies.

The projected increase in genetic (inherited) disorders is anticipated to be a key driver for the growth of the medical foods for inborn errors of metabolism market in the future. Genetic disorders, stemming from deviations in the typical DNA sequence, are expected to contribute to the demand for specialized nutrition provided by medical foods. These products play a crucial role in addressing the unique metabolic needs of individuals with metabolic abnormalities, preventing nutritional deficits, and promoting overall growth and well-being. For instance, data from May 2021 indicated that in the United States alone, a gene variant diagnosed 1 in 200,000 individuals with syndrome A each year, while globally, 15,000 patients with syndrome B have been identified. This surge in genetic disorders is a significant factor propelling the growth of the medical foods for inborn errors of metabolism market.

The growing aging population is poised to drive the expansion of the medical food for inborn errors of metabolism market in the coming years. The aging population trend, characterized by an increasing proportion of elderly individuals globally, presents challenges associated with nutritional requirements and metabolic issues specific to certain disorders in older individuals. Notably, projections from the World Health Organization in October 2022 estimate that by 2030, 1 in every 6 individuals worldwide will be 60 years old or older. During this period, the population aged 60 and over is expected to increase from 1 billion in 2020 to 1.4 billion. Looking ahead, the global population of individuals aged 60 and older is set to double, reaching 2.1 billion by 2050. As a result, the rising aging population emerges as a significant factor propelling the growth of the medical food for inborn errors of metabolism market.

Product innovation stands out as a prominent trend gaining traction in the medical food for inborn errors of metabolism market. Key players in this market are strategically focusing on the development of innovative products to enhance their market position. An example of this trend is evident in the actions of SFI Health, a Switzerland-based natural healthcare company, which introduced EQUAZEN PRO in December 2021. This specially formulated medical food caters to the dietary treatment of conditions with specific nutritional requirements for omega fatty acid levels. EQUAZEN PRO is designed to promote healthy fatty acid metabolism and restore optimal omega-heavy acid levels. Scientifically proven to improve brain health in children and adolescents with ADHD and associated neurodiverse diseases, EQUAZEN PRO contains sustainably sourced fish oils and evening primrose oil. The capsule shell composition ensures gastro resistance, delaying the transfer of fish oil from the stomach to the intestine and preventing potential fishy flavor or reflux.

Major companies in the medical food for inborn errors of metabolism market are also directing their efforts towards developing innovative metabolic products, such as solid-dose protein substitutes, to address dietary management needs and gain a competitive edge. A notable example is Galen Medical Nutrition, an Ireland-based company, which, in October 2022, introduced TYR EASY Tablets into the UK market. These unique solid-dose protein substitutes for tyrosinemia are provided in tablet form and cater to patients over the age of 8, offering more options for protein substitutes tailored to their daily requirements.

In June 2021, Vitaflo International, a UK-based clinical nutrition company, made a strategic acquisition by purchasing Dr. Schar products, Mevalia, and ComidaMed, along with its manufacturing facility in Germany. This acquisition, conducted for an undisclosed amount, enhances Vitaflo's product portfolio for Inborn Errors of Metabolism (IEM) and expands its geographic footprint. The acquired brands, Mevalia and ComidaMed, contribute to the dietary management of IEM and cow's milk protein allergy. Mevalia, in particular, specializes in protein supplements for phenylketonuria (PKU), while ComidaMed offers hypoallergenic powdered mixtures for IEM. This strategic move bolsters Vitaflo's position in the medical food for inborn errors of metabolism market.

Major companies operating in the medical foods for inborn errors of metabolism market report are BASF SE, Abbott Laboratories Inc., Danone SA, Bristol-Myers Squibb Co, Meiji Holdings Co Ltd., Nestle Health Science S.A., Ajinomoto Corporation, Mount Sinai Health System, BioMarin Pharmaceutical Inc., Gerber Products Company, Metagenics Inc., Vitaflo International, SHS International Limited, Merck $ Co Inc., Galen Medical Group, Applied Nutrition Corp., Primus Pharmaceuticals Inc., Reckitt Benckiser Group Plc, Ener-G Foods Inc., Pristine Organics Pvt. Ltd., Cymbiotika LLC, BC Children's Hospital, NutriScience Innovations LLC, Solace Nutrition LLC

North America was the dominant region in the medical foods for inborn errors of metabolism market in 2023. The regions covered in the medical foods for inborn errors of metabolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical foods for inborn errors of metabolism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical food for inborn errors of the metabolism market consists of sales of galactose-free formulas, modified starches and carbohydrate supplements, and Vitamin pyridoxine (B6) supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Foods For Inborn Errors Of Metabolism Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical foods for inborn errors of metabolism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical foods for inborn errors of metabolism ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical foods for inborn errors of metabolism market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Amino Acid; Glytactin with GMP Amino Acid-Modified Infant Formula with Iron; Low-Calcium/Vitamin D-Free Infant Formula with Iron; Low Protein Food; Other Products
  • 2) By Diseases: Phenylketonuria (PKU); Maple Syrup Urine Disease (MSUD); Homocystinuria; Methylmalonic Acidemia; Organic Acidurias; Propionic Acidemia; Isovaleric Acidemia; Disorders of Leucine Metabolism; Glutaric Acidemia Type I Renal Disease; Other Diseases
  • 3) By Age Group: Infants; Weaning; Adolescent; Adults
  • 4) By Forms: Powder; Liquids; Gels; Other Forms
  • 5) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Drugs Stores; Online Pharmacies; Other Distribution Channels
  • Companies Mentioned: BASF SE; Abbott Laboratories Inc; Danone SA; Bristol-Myers Squibb Co; Meiji Holdings Co Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Foods For Inborn Errors Of Metabolism Market Characteristics

3. Medical Foods For Inborn Errors Of Metabolism Market Trends And Strategies

4. Medical Foods For Inborn Errors Of Metabolism Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Medical Foods For Inborn Errors Of Metabolism Market Size and Growth

  • 5.1. Global Medical Foods For Inborn Errors Of Metabolism Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Medical Foods For Inborn Errors Of Metabolism Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Medical Foods For Inborn Errors Of Metabolism Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Medical Foods For Inborn Errors Of Metabolism Market Segmentation

  • 6.1. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Amino Acid
  • Glytactin with GMP Amino Acid-Modified Infant Formula with Iron
  • Low-Calcium/Vitamin D-Free Infant Formula with Iron
  • Low Protein Food
  • Other products
  • 6.2. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Phenylketonuria (PKU)
  • Maple Syrup Urine Disease (MSUD)
  • Homocystinuria
  • Methylmalonic Acidemia
  • Organic Acidurias
  • Propionic Acidemia
  • Isovaleric Acidemia
  • Disorders of Leucine Metabolism
  • Glutaric Acidemia Type I Renal Disease
  • Other Diseases
  • 6.3. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infants
  • Weaning
  • Adolescent
  • Adults
  • 6.4. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Powder
  • Liquids
  • Gels
  • Other Forms
  • 6.5. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Retail Pharmacies
  • Hospital Pharmacies
  • Drugs Stores
  • Online Pharmacies
  • Other Distribution Channel

7. Medical Foods For Inborn Errors Of Metabolism Market Regional And Country Analysis

  • 7.1. Global Medical Foods For Inborn Errors Of Metabolism Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Medical Foods For Inborn Errors Of Metabolism Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market

  • 8.1. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Medical Foods For Inborn Errors Of Metabolism Market

  • 9.1. China Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 9.2. China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Medical Foods For Inborn Errors Of Metabolism Market

  • 10.1. India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Medical Foods For Inborn Errors Of Metabolism Market

  • 11.1. Japan Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 11.2. Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Medical Foods For Inborn Errors Of Metabolism Market

  • 12.1. Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Medical Foods For Inborn Errors Of Metabolism Market

  • 13.1. Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Medical Foods For Inborn Errors Of Metabolism Market

  • 14.1. South Korea Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 14.2. South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Medical Foods For Inborn Errors Of Metabolism Market

  • 15.1. Western Europe Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 15.2. Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Medical Foods For Inborn Errors Of Metabolism Market

  • 16.1. UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Medical Foods For Inborn Errors Of Metabolism Market

  • 17.1. Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Medical Foods For Inborn Errors Of Metabolism Market

  • 18.1. France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Medical Foods For Inborn Errors Of Metabolism Market

  • 19.1. Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Medical Foods For Inborn Errors Of Metabolism Market

  • 20.1. Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market

  • 21.1. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 21.2. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Medical Foods For Inborn Errors Of Metabolism Market

  • 22.1. Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Medical Foods For Inborn Errors Of Metabolism Market

  • 23.1. North America Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 23.2. North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Medical Foods For Inborn Errors Of Metabolism Market

  • 24.1. USA Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 24.2. USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Medical Foods For Inborn Errors Of Metabolism Market

  • 25.1. Canada Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 25.2. Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Medical Foods For Inborn Errors Of Metabolism Market

  • 26.1. South America Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 26.2. South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Medical Foods For Inborn Errors Of Metabolism Market

  • 27.1. Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Medical Foods For Inborn Errors Of Metabolism Market

  • 28.1. Middle East Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 28.2. Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Medical Foods For Inborn Errors Of Metabolism Market

  • 29.1. Africa Medical Foods For Inborn Errors Of Metabolism Market Overview
  • 29.2. Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Medical Foods For Inborn Errors Of Metabolism Market Competitive Landscape And Company Profiles

  • 30.1. Medical Foods For Inborn Errors Of Metabolism Market Competitive Landscape
  • 30.2. Medical Foods For Inborn Errors Of Metabolism Market Company Profiles
    • 30.2.1. BASF SE
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danone SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bristol-Myers Squibb Co
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Meiji Holdings Co Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Medical Foods For Inborn Errors Of Metabolism Market Other Major And Innovative Companies

  • 31.1. Nestle Health Science S.A.
  • 31.2. Ajinomoto Corporation
  • 31.3. Mount Sinai Health System
  • 31.4. BioMarin Pharmaceutical Inc
  • 31.5. Gerber Products Company
  • 31.6. Metagenics Inc.
  • 31.7. Vitaflo International
  • 31.8. SHS International Limited
  • 31.9. Merck $ Co Inc.
  • 31.10. Galen Medical Group
  • 31.11. Applied Nutrition Corp.
  • 31.12. Primus Pharmaceuticals Inc.
  • 31.13. Reckitt Benckiser Group Plc
  • 31.14. Ener-G Foods Inc
  • 31.15. Pristine Organics Pvt. Ltd.

32. Global Medical Foods For Inborn Errors Of Metabolism Market Competitive Benchmarking

33. Global Medical Foods For Inborn Errors Of Metabolism Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Medical Foods For Inborn Errors Of Metabolism Market

35. Medical Foods For Inborn Errors Of Metabolism Market Future Outlook and Potential Analysis

  • 35.1 Medical Foods For Inborn Errors Of Metabolism Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Medical Foods For Inborn Errors Of Metabolism Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Medical Foods For Inborn Errors Of Metabolism Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer